192 related articles for article (PubMed ID: 10194140)
1. Transition of polycythemia vera to chronic neutrophilic leukemia.
Higuchi T; Oba R; Endo M; Harada H; Mori H; Niikura H; Omine M; Fujita K
Leuk Lymphoma; 1999 Mar; 33(1-2):203-6. PubMed ID: 10194140
[TBL] [Abstract][Full Text] [Related]
2. A case of transition of polycythemia vera to chronic neutrophilic leukemia.
Lee SS; Moon JH; Ha JW; Lee YK; Ahn JS; Zang DY; Kim HJ
Korean J Intern Med; 2004 Dec; 19(4):285-8. PubMed ID: 15683121
[TBL] [Abstract][Full Text] [Related]
3. [Polycythemia vera terminating in chronic neutrophilic leukemia: studies on in vitro growth of hematopoietic progenitor cells].
Fujisawa S; Matuzaki M; Harano H; Matomura S; Okubo T; Maruta A; Kodama F; Ikuta K; Sasaki H
Rinsho Ketsueki; 1992 Dec; 33(12):1863-8. PubMed ID: 1479700
[TBL] [Abstract][Full Text] [Related]
4. [A case of chronic neutrophilic leukemia accompanied with severe bone marrow fibrosis which was effectively treated by hydroxyurea].
Hirayama Y; Koda K; Matsumoto S; Takayanagi M; Ezoe A; Nobuoka A; Nakazawa O
Rinsho Ketsueki; 1994 Nov; 35(11):1329-34. PubMed ID: 7823400
[TBL] [Abstract][Full Text] [Related]
5. Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization.
Castelli R; Cugno M; Gianelli U; Pancrazzi A; Vannucchi AM
Pathol Res Pract; 2015 Apr; 211(4):341-3. PubMed ID: 25480691
[TBL] [Abstract][Full Text] [Related]
6. Chronic neutrophilic leukaemia: an Egyptian case.
Elbahrawy A; Hamdy M; Morsy MH; Ragab R
BMJ Case Rep; 2009; 2009():. PubMed ID: 21701572
[TBL] [Abstract][Full Text] [Related]
7. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
8. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
Alvarez-Larrán A; Martínez-Avilés L; Hernández-Boluda JC; Ferrer-Marín F; Antelo ML; Burgaleta C; Mata MI; Xicoy B; Martínez-Trillos A; Gómez-Casares MT; Durán MA; Marcote B; Ancochea A; Senín A; Angona A; Gómez M; Vicente V; Cervantes F; Bellosillo B; Besses C
Ann Hematol; 2014 Dec; 93(12):2037-43. PubMed ID: 24981691
[TBL] [Abstract][Full Text] [Related]
9. Chronic neutrophilic leukemia--a case report.
Chang CS; Lin SF; Hwang SM; Liu TC; Chen TP; Chiang W
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Mar; 11(3):181-5. PubMed ID: 7707468
[TBL] [Abstract][Full Text] [Related]
10. [Chronic neutrophilic leukemia: a long-term analysis of seven cases and review of the literature].
Telek B; Batár P; Udvardy M; László R
Orv Hetil; 2006 May; 147(18):827-30. PubMed ID: 16784137
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
[TBL] [Abstract][Full Text] [Related]
12. Chronic neutrophilic leukaemia associated with polycythemia vera: pathogenetic implications and therapeutic approach.
Foa P; Iurlo A; Saglio G; Guerrasio A; Capsoni F; Maiolo AT
Br J Haematol; 1991 Jun; 78(2):286-8. PubMed ID: 2064971
[No Abstract] [Full Text] [Related]
13. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
Michiels JJ; Barbui T; Finazzi G; Fuchtman SM; Kutti J; Rain JD; Silver RT; Tefferi A; Thiele J
Leuk Lymphoma; 2000 Jan; 36(3-4):239-53. PubMed ID: 10674896
[TBL] [Abstract][Full Text] [Related]
14. [Neutrophil alkaline phosphatase score].
Nakamura Y; Waga K; Mitani K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():785-8. PubMed ID: 15658450
[No Abstract] [Full Text] [Related]
15. Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease.
Böhm J; Schaefer HE
J Clin Pathol; 2002 Nov; 55(11):862-4. PubMed ID: 12401827
[TBL] [Abstract][Full Text] [Related]
16. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
[TBL] [Abstract][Full Text] [Related]
17. Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.
Sirhan S; Busque L; Foltz L; Grewal K; Hamm C; Laferriere N; Laneuville P; Leber B; Liew E; Olney HJ; Prchal J; Porwit A; Gupta V
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):715-27. PubMed ID: 26433906
[TBL] [Abstract][Full Text] [Related]
18. Busulfan versus hydroxyurea in the treatment of polycythemia vera (PV) and essential thrombocythemia (ET).
Brodsky I
Am J Clin Oncol; 1998 Feb; 21(1):105-6. PubMed ID: 9499248
[No Abstract] [Full Text] [Related]
19. Chronic neutrophilic leukemia--report of a case and review of the literature.
Wang JS; Ho CH; Lin CK
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):109-12. PubMed ID: 2177362
[TBL] [Abstract][Full Text] [Related]
20. Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders.
Randi ML; Ruzzon E; Luzzatto G; Tezza F; Girolami A; Fabris F
Haematologica; 2005 Feb; 90(2):261-2. PubMed ID: 15710584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
